Mini Review

Association of Sodium Levels with Clinico-Pathological Features in Gastric Carcinoma Patients in a Tertiary Care Hospital in Coastal Karnataka

Amulya Cherukumudi* and Nihaz Yusuf Nazer

Consultant, General Surgery, Regal Hospital, Bangalore, India

Published Date: 31/03/2021.

*Corresponding author:   Amulya Cherukumudi, Consultant,General Surgery, Regal Hospital, Bangalore, Karnataka ,India

DOI: 10.51931/OAJCS.2021.02.000022

Abstract

Background: Gastric Carcinoma is the 2nd most common malignancy in the southern part of India, and still is one of the leading causes of cancer specific morbidity and death. Hyponatremia or low serum sodium, is a commonly encountered dyselectrolytemia in clinical practice, including patients with cancer. However, there is little data available on the prevalence and causative factors of hyponatremia in gastric carcinoma patients.

Objective: To detect the Serum Sodium in patients with Gastric Carcinoma and to find the association of Sodium with the Clinico-Pathological features of Gastric Carcinoma

Methods and Materials: A retrospective, record based cross sectional study was conducted on 112 patients admitted during January 2016- April 2018. The data was recorded in a MS Excel Spreadsheet and analysed using SPSS v20.

Results: The most common presenting symptom among the patients was pain abdomen seen in 59(52.7%), followed by 30 (26.8%) with vomiting due to gastric outlet obstruction. The median duration of symptoms was found to 2[1-4] months. The most common site of the tumour was found to be Pylorus in 42 cases (36.5%). The mean sodium concentration was 134.35±7.0mEq/L. It was found that 52(47.3%) had hyponatremia and 24(21.8%) –mild hyponatremia. 27 (51.9%) of 60 patients with poorly differentiated adenocarcinoma had hyponatremia. The probability of patient having hyponatremia is higher with those having pain abdomen, generalized weakness, anaemia and those with poorly differentiated adenocarcinoma as diagnosed by UGI scopy guided biopsy.

Conclusion: The probability of patient having hyponatremia is higher with those having pain abdomen, generalized weakness, anaemia and those with poorly differentiated adenocarcinoma as diagnosed by UGI scopy

Keywords: Hyponatremia; Gastric Carcinoma; Sodium; Adenocarcinoma

Introduction

Gastric Carcinoma, as per the GLOBOCON 2018 data is the 5th most common malignancy and 3rd most lethal of all. It continues to be a significant cause of cancer specific morbidity and mortality [1]. Despite this, Gastric carcinoma is also the most behaviourally influenced malignancy, dependent heavily on our diet and associated Helicobacter Pylori infection. This makes it a preventable and curable malignancy [1]. Most of these patients present with non-specific symptoms and receive symptomatic treatment for the same. This delays the diagnosis, and hence patients are often diagnosed with progressive disease, and are usually inoperable. Hyponatremia is a common electrolyte abnormality that is encountered in clinically practice, and patients with malignancy as well [1,2]. Hyponatremia is when serum sodium is found to be lower than 135 mmol/L, with or without the presence of symptoms for the same [3-5]. Hyponatremia was further classified as mild 131-135 mmol/L, moderate 125-130 mmol/L, severe below 125 mmol/L, by Joint European Guidelines [6]. These values are a guide for hyponatremia assessment in the absence of symptoms. While in most cases, hyponatremia is often detected during the diagnosis of gastric carcinoma; in few cases it precedes the same. There are very few studies that demonstrate the association of sodium levels with the clinic-pathological features of gastric carcinoma.

Objectives

To determine the Serum Sodium levels in the patients of Gastric Carcinoma

To determine the association of Serum Sodium levels with the Clinico-Pathological features in Gastric Carcinoma

Methodology

This is a retrospective, record based cross sectional study was conducted on 112 patients admitted and diagnosed with Gastric Carcinoma during Jan 2016- April 2018 in Justice K.S. Hedge Charitable hospital, Mangalore. Based on the hospital database, details such as age, sex, complaints, upper GI endoscopy findings, biopsy report, serum sodium and haemoglobin reports on admission were collected. Any case record that had any of the above data missing was excluded from the study. The data was then recorded in a preformed, semi-structured pro forma. The serum sodium level was classified as mild 131-135 mmol/L, moderate 125-130 mmol/L, severe below 125 mmol/L. Any symptoms mentioned in the case history that was suggestive of hyponatremia were also noted. This study was approved by the institutional ethics committee of K. S. Hegde Medical Academy, Deralakatte, Mangalore. Statistical analysis- The data collected was analyzed using SPSS software version 20.0. Mean, median, Inter-quartile range and chi square and Spearman's correlation was calculated where appropriate. Any inference was considered to be statistically significant if the p value was found to be less than 0.05 in our study.

Results

The patients included in this study were diagnosed with carcinoma stomach following UGI scopy and biopsy. It was observed that 82 (73.2%) of the study participants were males and the median age of patients with carcinoma stomach was 60[54.0-65.0]. The most common presenting symptom among the patients was pain abdomen seen in 59(52.7%), followed by 30 (26.8%) with vomiting due to gastric outlet obstruction. The median duration of symptoms was found to 2 [1-4] months. Of the 112 patients, 72(62.6%) had no detectable abnormality on per abdomen examination. The most common feature found in Upper GI SCOPY findings was ulcero-proliferative lesion which was seen in 67(58.3%), with the most common site of the lesion was the pylorus – 42(36.5%) of the patient followed by the body of the stomach seen in 22(19.1%).

Of the 112 participants, 61 (54.5%) showed poorly differentiated adenocarcinoma on UGI scopy histopathology. Mean haemoglobin was 10.37±2.7 g, 56(50.5%) were anaemic. Mean sodium concentration was 134.35±7.0mEq/L; 54(48.2%) of the patients had hyponatremia of which 24(21.8%) of the patients experienced mild hyponatremia (Table 1,2 & Figure 1). Of the 60 patients with poorly differentiated adenocarcinoma, 28 (46.6%) experienced hyponatremia (Table 3 & Figure 2). Hyponatremia was significantly associated with and showed a weak correlation between pain abdomen, generalized weakness, duration of symptoms, haemoglobin. Hyponatremia was significantly associated with poorly differentiated adenocarcinoma.

Figure 1: Distribution of hyponatremia.

Figure 2: Comparison of UGI scopy and the Serum Sodium levels.

Table 1: Distribution of patient based on Serum Sodium values.

1: Severe /profound; 2: Moderate; 3: Mild; 4: Normal sodium

Table 2: Grading of patients based on Hyponatremia level.

Table 3: Comparison of UGI scopy and the Serum Sodium levels.

Discussion

Gastric carcinoma is a commonly encountered gastrointestinal malignancy. Although there is a significant decrease in the incidence of gastric carcinoma as per worldwide statistics, it is still found to be an important cause of cancer related morbidity and deaths in developing nations [7]. It is still the 2nd most frequently encountered gastrointestinal malignancy in the southern states of India. Most of these patients present with vague symptoms of abdominal discomfort/pain, vomiting and generalized weakness etc. This contributes to the delay in diagnosis and treatment, making most patients inoperable at final clinical and radiological evaluation.

Hyponatremia is a frequently occurring electrolyte abnormality in cancer patients. It contributes to the pre-existing morbidity, and is most often asymptomatic. In our study, patients were diagnosed to have gastric carcinoma through a biopsy done during UGI scopy [2]. It was retrospectively found that patients on admission had hyponatremia i.e. serum sodium less than 135 mmol/L. Of the 112 patients that fit the inclusion criteria, 52 were found to have hyponatremia; 24 of these patients were found to have mild hyponatremia. However, it was observed that most of the patients with hyponatremia were asymptomatic, with pain abdomen/abdominal discomfort being the predominant presenting complaint. In our study, almost half the patients experienced hyponatremia, of which 24 patients had mild hyponatremia. Asymptomatic hyponatremia in clinical practice seldom warrants correction, however it may not be true for cancer patients. Studies have shown that hyponatremia associated with malignancies increase the morbidity and mortality. The common causes of hyponatremia in GI malignancies are irrelevant electrolyte and fluid loss due to shedding of the GI mucosa, which maybe induced by chemotherapeutic agents (2). However, in our study we observed significant hyponatremia in patients prior to any definitive treatment, either medical or surgical. Several studies have shown that syndrome of inappropriate antidiuretic hormone (SIADH) maybe responsible for the hyponatremia in such patients. This is most commonly seen in lung malignancies due to ectopic ADH production or in renal cell carcinoma; there are very few studies to demonstrate the same in gastric carcinoma. ADH secretion can be precipitated due to pain, vomiting, and use of opioid drugs for pain management [2-5].

It is also observed in our study that gastric carcinoma patients with hyponatremia also had associated anaemia, which further contributes to the morbidity. Poorly differentiated adenocarcinoma is found to be an independent prognostic factor in predicting outcomes in gastric carcinoma patients.

Limitations

Since this is a retrospective study, analysis on the cause of the hyponatremia couldn’t be evaluated. Also, its value as a prognostic factor in gastric carcinoma patients could not be assessed.

Conclusion

The probability of patient having hyponatremia is higher with those having pain abdomen, generalized weakness, anaemia and those with poorly differentiated adenocarcinoma as diagnosed by UGI scopy. Further prospective studies are required to pinpoint the cause of the hyponatremia and its implication in the management of gastric carcinoma.

References

Subscribe to newsletter

© 2020. All rights reserved.

TOP